Investopedia |
Amgen’s Repatha lowers heart attack, stroke risk
MarketWatch Researchers found that Amgen Inc.’s new cholesterol-lowering drug Repatha reduced the risk of deaths, heart attacks and strokes by 20% compared with standard treatment with statin drugs, a benefit that the biotech hopes will persuade health insurers to … Amgen’s Repatha Cut Stroke, Heart Attack Risk (AMGN) Amgen cholesterol drug cuts heart attack, stroke risk but shares fall Amgen Cholesterol Drug Cuts Risk of Heart Attack, Stroke but Not … |
19
MAR
MAR
0